When it comes to making biologic drugs like vaccines and monoclonal antibodies, safety is everything. You want drugs that do their job without causing side effects. One of the big challenges in this process is ensuring that leftover proteins from the host cells — proteins that aren’t supposed to be in the final drug — are kept under strict control. That’s where the China...
English
Arabic
French
Spanish
Portuguese
Deutsch
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek